Microbot Robotic Surgical System FDA-Approved to Begin Human Trials

Microbot Medical, a surgical robotics company, has announced the FDA approval to start its human clinical trials for the Liberty Endovascular Robotic Surgical System.

The Liberty system was designed, according to the company, for single use procedures to reduce exposure to radiation and eliminate user physical strain when operating seated away from radiation source. The system has a small footprint, having no required dedicated infrastructure, can be used in multiple sites, and is designed to utilize off-the-shelf instruments.